Your browser doesn't support javascript.
loading
PARP-1 Expression Quantified by [18F]FluorThanatrace: A Biomarker of Response to PARP Inhibition Adjuvant to Radiation Therapy.
Sander Effron, Samuel; Makvandi, Mehran; Lin, Lilie; Xu, Kuiying; Li, Shihong; Lee, Hsiaoju; Hou, Catherine; Pryma, Daniel A; Koch, Cameron; Mach, Robert H.
Afiliação
  • Sander Effron S; 1 Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania.
  • Makvandi M; 1 Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania.
  • Lin L; 2 Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania.
  • Xu K; 1 Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania.
  • Li S; 1 Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania.
  • Lee H; 1 Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania.
  • Hou C; 1 Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania.
  • Pryma DA; 1 Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania.
  • Koch C; 2 Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania.
  • Mach RH; 1 Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania.
Cancer Biother Radiopharm ; 32(1): 9-15, 2017 Feb.
Article em En | MEDLINE | ID: mdl-28118040
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Biomarcadores Farmacológicos / Inibidores de Poli(ADP-Ribose) Polimerases / Poli(ADP-Ribose) Polimerase-1 Limite: Female / Humans Idioma: En Revista: Cancer Biother Radiopharm Assunto da revista: FARMACIA / FARMACOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Biomarcadores Farmacológicos / Inibidores de Poli(ADP-Ribose) Polimerases / Poli(ADP-Ribose) Polimerase-1 Limite: Female / Humans Idioma: En Revista: Cancer Biother Radiopharm Assunto da revista: FARMACIA / FARMACOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2017 Tipo de documento: Article